Pfizer Inc. (PFE)
28.45
-0.36
(-1.25%)
USD |
NYSE |
Sep 04, 16:00
28.42
-0.03
(-0.11%)
After-Hours: 20:00
Pfizer Price : 28.45 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 28.58 | 28.69 | 28.38 | 28.45 | 23.79M |
| Sep 03, 2026 | 29.09 | 29.21 | 28.44 | 28.81 | 26.72M |
| Sep 02, 2026 | 28.79 | 29.09 | 28.70 | 29.02 | 39.28M |
| Sep 01, 2026 | 28.82 | 29.09 | 28.46 | 28.55 | 42.49M |
| Aug 31, 2026 | 27.85 | 28.70 | 27.64 | 28.46 | 45.93M |
| Aug 28, 2026 | 28.00 | 28.02 | 27.77 | 27.96 | 27.18M |
| Aug 27, 2026 | 27.97 | 28.18 | 27.83 | 28.02 | 31.17M |
| Aug 26, 2026 | 28.44 | 28.50 | 28.14 | 28.30 | 35.07M |
| Aug 25, 2026 | 27.92 | 28.58 | 27.84 | 28.57 | 31.92M |
| Aug 24, 2026 | 28.10 | 28.16 | 27.81 | 27.97 | 23.85M |
| Aug 21, 2026 | 27.77 | 28.42 | 27.66 | 28.07 | 37.11M |
| Aug 20, 2026 | 28.00 | 28.16 | 27.64 | 27.79 | 29.30M |
| Aug 19, 2026 | 27.60 | 28.44 | 27.58 | 28.24 | 59.80M |
| Aug 18, 2026 | 27.15 | 27.40 | 27.10 | 27.25 | 34.66M |
| Aug 17, 2026 | 26.76 | 27.02 | 26.55 | 26.87 | 29.26M |
| Aug 14, 2026 | 26.66 | 26.92 | 26.42 | 26.79 | 23.17M |
| Aug 13, 2026 | 26.49 | 26.95 | 26.41 | 26.80 | 35.36M |
| Aug 12, 2026 | 26.38 | 26.44 | 26.18 | 26.31 | 32.59M |
| Aug 11, 2026 | 26.94 | 27.20 | 26.47 | 26.62 | 37.94M |
| Aug 10, 2026 | 26.58 | 27.19 | 26.52 | 27.05 | 49.79M |
| Aug 07, 2026 | 26.22 | 26.76 | 26.05 | 26.76 | 42.74M |
| Aug 06, 2026 | 26.01 | 26.20 | 25.81 | 26.20 | 51.07M |
| Aug 05, 2026 | 25.50 | 25.81 | 25.30 | 25.81 | 47.06M |
| Aug 04, 2026 | 25.04 | 25.64 | 24.70 | 25.41 | 62.19M |
| Aug 03, 2026 | 25.15 | 25.39 | 24.86 | 25.03 | 40.65M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 275.23 |
| Eli Lilly & Co. | 1149.36 |
| Merck & Co., Inc. | 150.33 |
| Bristol Myers Squibb Co. | 66.82 |
| Viatris, Inc. | 16.88 |
Price Related Metrics
| PE Ratio | 37.67 |
| PS Ratio | 2.549 |
| Price to Book Value | 1.903 |
| Price to Free Cash Flow | 14.78 |
| Earnings Yield | 2.65% |
| Market Cap | 162.14B |
| Operating PE Ratio | 9.593 |
| Normalized PE Ratio | 11.74 |